Tag: Zalika Farmacêutica

• Thursday, January 11th 2024 - 11:06 UTC

  Brazilian-developed vaccine against Covid-19 registered by Anvisa

  

  The new vaccine against Covid-19 developed by the Brazilian company Zalika Farmacêutica has been entered into the National Health Surveillance Agency (Anvisa) this week, Agencia Brasil reported. The drug can be used in people aged 12 and over and is to be administered in two doses, 21 days apart, with boosters after 6 months for those over 18 years of age.